What is the current Price Target for the Gain Therapeutics Inc stock?

The average Gain Therapeutics Inc target price is $8.16. This is 374.42% higher than the current stock price. The highest price target is 388.37%, the lowest is 193.60%. 7 Analysts have issued a price target Gain Therapeutics Inc 2027 .

How high will the Gain Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Gain Therapeutics Inc stock will rise. The performance of stocks, including the Gain Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Gain Therapeutics Inc stock today?

The performance of Gain Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Gain Therapeutics Inc stock fall?

The decline in Gain Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Gain Therapeutics Inc Forecast, price target & analysts

$1.72

0.58%

Nasdaq, Oct 01, 04:00 pm EDT. Closed.

ISIN

US36269B1052

Symbol

GANX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Gain Therapeutics Inc Target price 2026 - Analyst rating & recommendation

Gain Therapeutics Inc Classifications & Recommendation

Buy

91%

Hold

Gain Therapeutics Inc Price Target

Target Price	$8.16
Price	$1.72
Potential	374.42% register free of charge
Number of Estimates	7

	7 Analysts have issued a price target Gain Therapeutics Inc 2027 . The average Gain Therapeutics Inc target price is $8.16. This is 374.42% register free of charge higher than the current stock price. The highest price target is $8.40 388.37% register free of charge , the lowest is $5.05 193.60% register free of charge .
	A rating was issued by 11 analysts: 10 Analysts recommend Gain Therapeutics Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Gain Therapeutics Inc stock has an average upside potential 2027 of 374.42% register free of charge . Most analysts recommend the Gain Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
P/E		negative

7 Analysts have issued a Gain Therapeutics Inc forecast for earnings per share. The average Gain Therapeutics Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2027	$-0.70 34.62% unlock
2028	$-0.86 22.86% unlock
2029	$-0.29 66.28% unlock
2030	$-0.36 24.14% unlock
2031	$1.69 569.44% unlock
2032	$3.90 130.77% unlock

Current
2026	-3.34 10.67% unlock
2027	-2.45 26.65% unlock
2028	-2.01 17.96% unlock
2029	-6.02 199.50% unlock

Gain Therapeutics Inc...

Current Gain Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 31 2026
BTIG	Locked ➜ Locked	Locked	Aug 11 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jul 01 2026
BTIG	Locked ➜ Locked	Locked	Jun 30 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 19 2025
BTIG	Locked ➜ Locked	Locked	Oct 15 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 13 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 31 2026
Locked BTIG: Locked ➜ Locked	Aug 11 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Jul 01 2026
Locked BTIG: Locked ➜ Locked	Jun 30 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 19 2025
Locked BTIG: Locked ➜ Locked	Oct 15 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 13 2025

Discover more stocks with a high price target

NIO ADR 85.25%

Alibaba Group Holding Ltd 78.14%

Rheinmetall 72.55%

Tencent Holdings Ltd. 57.61%

Adyen 57.36%

Infineon 55.35%

Uber Technologies 51.77%

BYD 46.92%

Siemens Energy 46.72%

TUI 45.17%

Adidas 43.01%

Netflix 42.06%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now